AA-139

N/A

Report date: 2026/01/29 16:01:11
NME

Base Information

Drug NameAA-139
Drug Alias NameArenicinNZ-17000 seriesArenicin-3NZ-17211AA-139 +[6] 
ClassificationSmall molecules > Heterocyclic drugs > AntibioticsNatural product/Extract > Animal extract
Mechanisms of ActionAntibacterial multidrug resistance inhibitors
TargetsUpdating
Therapy Area/IndicationsMultidrug-Resistant InfectionKlebsiella InfectionsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovozymes
China Registration ClassN/A

Develop Information

Active CompaniesErasmus University Medical Center
Inactive CompaniesAdenium Biotech ApSNovozymes
Active IndicationsKlebsiella Infections
Inactive IndicationsMultidrug-Resistant InfectionGram-Negative Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A